Morgan Stanley Issues Pessimistic Forecast for Bath & Body Works (NYSE:BBWI) Stock Price

Bath & Body Works (NYSE:BBWI) had its price objective reduced by analysts at Morgan Stanley from $19.00 to $18.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley’s price objective indicates a potential downside of 33.90% from the company’s previous close.

A number of other research analysts have also issued reports on BBWI. UBS Group reduced their price target on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating for the company in a research report on Friday, August 29th. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the stock an “overweight” rating in a research report on Thursday, May 15th. JPMorgan Chase & Co. boosted their price target on Bath & Body Works from $40.00 to $46.00 and gave the stock an “overweight” rating in a research report on Monday, July 28th. Barclays upped their price objective on Bath & Body Works from $30.00 to $32.00 and gave the company an “equal weight” rating in a report on Friday, August 29th. Finally, Wall Street Zen lowered Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Bath & Body Works has an average rating of “Moderate Buy” and a consensus target price of $39.69.

Bath & Body Works Stock Performance

Shares of BBWI stock opened at $27.23 on Friday. Bath & Body Works has a 1 year low of $24.94 and a 1 year high of $41.87. The stock has a fifty day moving average of $30.31 and a two-hundred day moving average of $30.09. The firm has a market capitalization of $5.61 billion, a PE ratio of 8.08, a price-to-earnings-growth ratio of 0.95 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same quarter in the previous year, the firm posted $0.37 EPS. The firm’s quarterly revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities research analysts predict that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Bath & Body Works

A number of institutional investors and hedge funds have recently modified their holdings of BBWI. Captrust Financial Advisors raised its position in shares of Bath & Body Works by 36.5% during the fourth quarter. Captrust Financial Advisors now owns 21,918 shares of the company’s stock worth $850,000 after purchasing an additional 5,859 shares during the period. Cetera Investment Advisers raised its position in shares of Bath & Body Works by 18.4% during the fourth quarter. Cetera Investment Advisers now owns 24,877 shares of the company’s stock worth $964,000 after purchasing an additional 3,858 shares during the period. Lazard Asset Management LLC raised its position in shares of Bath & Body Works by 20.4% during the fourth quarter. Lazard Asset Management LLC now owns 22,336 shares of the company’s stock worth $864,000 after purchasing an additional 3,781 shares during the period. Nuveen Asset Management LLC raised its position in shares of Bath & Body Works by 3.7% during the fourth quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company’s stock worth $29,628,000 after purchasing an additional 27,136 shares during the period. Finally, Nomura Holdings Inc. acquired a new stake in shares of Bath & Body Works during the fourth quarter worth $226,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.